Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only

NCT05619588 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 370

Last updated 2025-02-27

No results posted yet for this study

Summary

The objectives of this study are to evaluate the performance and safety of the Vantage Total Ankle System. This study will follow subjects for a period of up to 10 years post-surgery.

Conditions

  • Ankle Rheumatoid Arthritis
  • Arthritis of Ankle
  • Failure, Prosthesis

Sponsors & Collaborators

  • Exactech

    lead INDUSTRY

Principal Investigators

  • Samuel Adams, MD · Duke Department of Orthopaedic Surgery

  • Edward Haupt, MD · Mayo Clinic

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-04
Primary Completion
2030-12-31
Completion
2031-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05619588 on ClinicalTrials.gov